These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 27166919)

  • 1. Molecular Profiling and Malignant Behavior Define Two Rat Mammary Tumor Cell Lines as a Relevant Experimental Model.
    Vela E; Escrich E
    J Cell Biochem; 2016 Dec; 117(12):2825-2834. PubMed ID: 27166919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting LA7 breast cancer stem cells of rat through repressing the genes of stemness-related transcription factors using three different biological fluids.
    Pourbagher R; Akhavan-Niaki H; Jorsaraei SGA; Fattahi S; Sabour D; Zabihi E; Abedian Z; Ghasemi M; Golpour M; Mostafazadeh A
    Gene; 2020 Apr; 734():144381. PubMed ID: 31978510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells.
    Pommier SJ; Quan GG; Christante D; Muller P; Newell AE; Olson SB; Diggs B; Muldoon L; Neuwelt E; Pommier RF
    Ann Surg Oncol; 2010 Feb; 17(2):613-23. PubMed ID: 19838757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The properties of a mammary gland cancer stem cell.
    Zucchi I; Sanzone S; Astigiano S; Pelucchi P; Scotti M; Valsecchi V; Barbieri O; Bertoli G; Albertini A; Reinbold RA; Dulbecco R
    Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10476-81. PubMed ID: 17566110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines.
    Michishita M; Akiyoshi R; Yoshimura H; Katsumoto T; Ichikawa H; Ohkusu-Tsukada K; Nakagawa T; Sasaki N; Takahashi K
    Res Vet Sci; 2011 Oct; 91(2):254-60. PubMed ID: 21190702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
    Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
    Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1-dependent induction of luminal inflammatory breast tumors by activated notch3.
    Ling H; Sylvestre JR; Jolicoeur P
    Cancer Res; 2013 Oct; 73(19):5963-73. PubMed ID: 23928992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44+/CD24- Cancer Stem Cells Are Associated With Higher Grade of Canine Mammary Carcinomas.
    Im KS; Jang YG; Shin JI; Kim NH; Lim HY; Lee SM; Kim JH; Sur JH
    Vet Pathol; 2015 Nov; 52(6):1041-4. PubMed ID: 26173453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mahanine, A dietary phytochemical, represses mammary tumor burden in rat and inhibits subtype regardless breast cancer progression through suppressing self-renewal of breast cancer stem cells.
    Das M; Kandimalla R; Gogoi B; Dutta KN; Choudhury P; Devi R; Dutta PP; Talukdar NC; Samanta SK
    Pharmacol Res; 2019 Aug; 146():104330. PubMed ID: 31251988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer.
    Wahler J; So JY; Cheng LC; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():148-55. PubMed ID: 25445919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell/metastasis-associated gene signature.
    Bonuccelli G; Casimiro MC; Sotgia F; Wang C; Liu M; Katiyar S; Zhou J; Dew E; Capozza F; Daumer KM; Minetti C; Milliman JN; Alpy F; Rio MC; Tomasetto C; Mercier I; Flomenberg N; Frank PG; Pestell RG; Lisanti MP
    Am J Pathol; 2009 May; 174(5):1650-62. PubMed ID: 19395651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myoepithelial and luminal breast cancer cells exhibit different responses to all-trans retinoic acid.
    Berardi DE; Flumian C; Campodónico PB; Urtreger AJ; Diaz Bessone MI; Motter AN; Bal de Kier Joffé ED; Farias EF; Todaro LB
    Cell Oncol (Dordr); 2015 Aug; 38(4):289-305. PubMed ID: 26044847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
    Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
    Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of stem cell protein Piwil2 and piR-932 in breast cancer.
    Zhang H; Ren Y; Xu H; Pang D; Duan C; Liu C
    Surg Oncol; 2013 Dec; 22(4):217-23. PubMed ID: 23992744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
    Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
    Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.
    Shao J; Fan W; Ma B; Wu Y
    Mol Med Rep; 2016 Dec; 14(6):4991-4998. PubMed ID: 27840965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44(+)/CD24(-/low)): an in vitro study.
    Ahmadipour F; Noordin MI; Mohan S; Arya A; Paydar M; Looi CY; Keong YS; Siyamak EN; Fani S; Firoozi M; Yong CL; Sukari MA; Kamalidehghan B
    Drug Des Devel Ther; 2015; 9():1193-208. PubMed ID: 25759564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
    So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer stem cells: a case of mistaken identity?
    Polyak K
    Stem Cell Rev; 2007 Jun; 3(2):107-9. PubMed ID: 17873341
    [No Abstract]   [Full Text] [Related]  

  • 20. Breast cancer stem cells: the other side of the story.
    Wicha MS
    Stem Cell Rev; 2007 Jun; 3(2):110-2; discussion 113. PubMed ID: 17873342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.